Factors of Influence, Economy and Policy -- Research & Analysis

Factors of Influence, Economy and Policy -- Research & Analysis on
Celgene Corporation and Teva Pharmaceutical Industries Limited 
JAKARTA, INDONESIA -- (Marketwire) -- 10/26/12 --  Moments ago,
TradersInsight.net introduced new coverage of Celgene Corporation
(NASDAQ: CELG) and Teva Pharmaceutical Industries Limited (NYSE:
TEVA). Full outlook, analysis and consensus opinion is available to
readers via the links
The consistent delivery of accurate analyses relies solely on two
factors, namely: market awareness and industry insight. Recent market
drivers include a rise in new home sales to 5.7% in September to an
annualized pace of 389,000 units, slightly stronger than market
expectations for an increase to 385,000, recent confirmation of
continued monetary stimulus and an unchanged FOMC policy and recent
moderation of existing home sales in the US to 4.75 million
annualized units in September 2012 from 4.83 million reported in the
previous month. When it comes to discovering the right edge at the
right time, all these factors play into effect. For a deeper
understanding of the mechanics behind these events and how it can
affect your portfolio, please refer to our email newsletter delivered
to your inbox. 
Traders Insight is releasing new coverage on Celgene Corporation for
its current position within the consumer durables sector. Celgene
Corporation is a global biopharmaceutical company engaged in the
discovery, development and commercialization of therapies designed to
treat cancer and immune-inflammatory related diseases. A copy of this
report featuring Celgene Corporation (NASDAQ: CELG) is available at:
Traders Insight has released research on Teva Pharmaceutical
Industries Limited for its changing role within the consumer durables
sector. Teva Pharmaceutical Industries Ltd (Teva) is a global
pharmaceutical and drug company. It develops, produces and markets
generic drugs in all treatment categories. The Company has a
pharmaceutical business, whose principal products include Copaxone
and Azilect. To access the full research report on Teva
Pharmaceutical Industries Limited (NYSE: TEVA) we welcome investors
to visit: www.TradersInsight.net/r/cnbc/24c9_TEVA. 
About Traders Insight
 Find direction and insight with
TradersInsight.net. Our model of enabling open collaboration between
members is breaking new ground into the investment community. By
tapping into the resources of the community, we are crowd-sourcing
our reach. As a result -- we have been able to identify some of the
greatest moving companies on the market today. The evidence is in the
results, join today and experience what you've been missing. 
Cora S. Patton
Press spacebar to pause and continue. Press esc to stop.